Rhenman & Partners Asset Management AB as of Sept. 30, 2018
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 88 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CIGNA Corporation | 3.6 | $36M | 175k | 208.25 | |
| CVS Caremark Corporation (CVS) | 3.5 | $35M | 439k | 78.72 | |
| Alexion Pharmaceuticals | 3.4 | $34M | 243k | 139.01 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.8 | $28M | 143k | 192.74 | |
| Incyte Corporation (INCY) | 2.6 | $26M | 377k | 69.08 | |
| BioMarin Pharmaceutical (BMRN) | 2.6 | $26M | 265k | 96.97 | |
| Abiomed | 2.5 | $25M | 56k | 449.76 | |
| Medtronic (MDT) | 2.5 | $25M | 250k | 98.37 | |
| UnitedHealth (UNH) | 2.4 | $24M | 91k | 266.04 | |
| Diplomat Pharmacy | 2.3 | $23M | 1.2M | 19.41 | |
| Exelixis (EXEL) | 2.2 | $22M | 1.3M | 17.72 | |
| Jazz Pharmaceuticals (JAZZ) | 2.1 | $21M | 126k | 168.13 | |
| Novocure Ltd ord (NVCR) | 2.1 | $21M | 400k | 52.40 | |
| Becton, Dickinson and (BDX) | 2.1 | $21M | 80k | 261.00 | |
| Bristol Myers Squibb (BMY) | 2.0 | $21M | 330k | 62.08 | |
| Sangamo Biosciences (SGMO) | 2.0 | $20M | 1.2M | 16.95 | |
| Abbott Laboratories (ABT) | 1.9 | $19M | 265k | 73.36 | |
| Anthem (ELV) | 1.9 | $19M | 70k | 274.06 | |
| Nektar Therapeutics (NKTR) | 1.9 | $19M | 305k | 60.96 | |
| Eli Lilly & Co. (LLY) | 1.8 | $18M | 170k | 107.31 | |
| Glaukos (GKOS) | 1.8 | $18M | 281k | 64.90 | |
| Humana (HUM) | 1.8 | $18M | 53k | 338.53 | |
| Horizon Pharma | 1.8 | $18M | 917k | 19.58 | |
| Sage Therapeutics (SAGE) | 1.8 | $18M | 125k | 141.25 | |
| Arena Pharmaceuticals | 1.7 | $17M | 366k | 46.02 | |
| Edwards Lifesciences (EW) | 1.7 | $17M | 97k | 174.10 | |
| Celgene Corporation | 1.6 | $16M | 181k | 89.49 | |
| Esperion Therapeutics (ESPR) | 1.6 | $16M | 354k | 44.37 | |
| Fibrogen (FGEN) | 1.5 | $15M | 251k | 60.75 | |
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $15M | 172k | 87.52 | |
| Gilead Sciences (GILD) | 1.5 | $15M | 190k | 77.21 | |
| Iovance Biotherapeutics (IOVA) | 1.4 | $15M | 1.3M | 11.25 | |
| Intra Cellular Therapies (ITCI) | 1.4 | $14M | 655k | 21.70 | |
| Seattle Genetics | 1.4 | $14M | 180k | 77.12 | |
| Allergan | 1.3 | $13M | 70k | 190.48 | |
| Boston Scientific Corporation (BSX) | 1.3 | $13M | 338k | 38.50 | |
| Alkermes (ALKS) | 1.3 | $13M | 302k | 42.44 | |
| Abbvie (ABBV) | 1.2 | $12M | 130k | 94.58 | |
| Myokardia | 1.2 | $12M | 188k | 65.20 | |
| Livanova Plc Ord (LIVN) | 1.2 | $12M | 95k | 123.97 | |
| Array BioPharma | 1.2 | $12M | 768k | 15.20 | |
| Agios Pharmaceuticals (AGIO) | 1.1 | $11M | 145k | 77.12 | |
| Aerie Pharmaceuticals | 1.1 | $11M | 180k | 61.55 | |
| Biogen Idec (BIIB) | 1.1 | $11M | 30k | 353.30 | |
| Walgreen Boots Alliance (WBA) | 1.1 | $11M | 145k | 72.90 | |
| Aetna | 1.0 | $10M | 50k | 202.86 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $10M | 82k | 122.95 | |
| Flexion Therapeutics | 1.0 | $10M | 533k | 18.71 | |
| AmerisourceBergen (COR) | 0.9 | $9.4M | 102k | 92.22 | |
| Immunomedics | 0.9 | $8.9M | 425k | 20.83 | |
| Loxo Oncology | 0.9 | $8.5M | 50k | 170.84 | |
| Xencor (XNCR) | 0.8 | $8.2M | 210k | 38.97 | |
| Spark Therapeutics | 0.8 | $7.5M | 138k | 54.55 | |
| Macrogenics (MGNX) | 0.7 | $7.3M | 342k | 21.44 | |
| Omnicell (OMCL) | 0.7 | $7.2M | 100k | 71.90 | |
| Regeneron Pharmaceuticals (REGN) | 0.7 | $6.9M | 17k | 404.06 | |
| Rigel Pharmaceuticals (RIGL) | 0.7 | $6.8M | 2.1M | 3.21 | |
| Portola Pharmaceuticals | 0.7 | $6.5M | 242k | 26.63 | |
| Centene Corporation (CNC) | 0.6 | $5.8M | 40k | 144.78 | |
| Mednax (MD) | 0.6 | $5.8M | 125k | 46.66 | |
| Adamas Pharmaceuticals | 0.6 | $5.5M | 274k | 20.02 | |
| Coherus Biosciences (CHRS) | 0.6 | $5.5M | 331k | 16.50 | |
| Revance Therapeutics (RVNC) | 0.5 | $5.0M | 203k | 24.85 | |
| Viewray (VRAYQ) | 0.5 | $4.8M | 517k | 9.36 | |
| Medicines Company | 0.4 | $4.0M | 135k | 29.91 | |
| Zogenix | 0.3 | $3.0M | 60k | 49.60 | |
| Achillion Pharmaceuticals | 0.2 | $2.3M | 618k | 3.68 | |
| Pieris Pharmaceuticals (PIRS) | 0.2 | $1.7M | 300k | 5.60 | |
| Chimerix (CMRX) | 0.1 | $1.3M | 341k | 3.89 | |
| Patterson Companies (PDCO) | 0.1 | $941k | 39k | 24.44 | |
| Adverum Biotechnologies | 0.1 | $932k | 154k | 6.05 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $855k | 428k | 2.00 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $520k | 6.1k | 85.09 | |
| Chevron Corporation (CVX) | 0.1 | $456k | 3.7k | 122.15 | |
| Qualcomm (QCOM) | 0.1 | $466k | 6.5k | 71.96 | |
| JPMorgan Chase & Co. (JPM) | 0.0 | $420k | 3.7k | 112.72 | |
| Pfizer (PFE) | 0.0 | $386k | 8.8k | 44.09 | |
| Walt Disney Company (DIS) | 0.0 | $407k | 3.5k | 116.85 | |
| Halliburton Company (HAL) | 0.0 | $374k | 9.2k | 40.56 | |
| International Business Machines (IBM) | 0.0 | $372k | 2.5k | 151.16 | |
| Microsoft Corporation (MSFT) | 0.0 | $330k | 2.9k | 114.31 | |
| Wells Fargo & Company (WFC) | 0.0 | $308k | 5.9k | 52.58 | |
| Ford Motor Company (F) | 0.0 | $300k | 32k | 9.26 | |
| Anheuser-Busch InBev NV (BUD) | 0.0 | $332k | 3.8k | 87.65 | |
| Janus Henderson Group Plc Ord (JHG) | 0.0 | $319k | 12k | 26.97 | |
| Symantec Corporation | 0.0 | $207k | 9.7k | 21.27 | |
| Alphabet Inc Class A cs (GOOGL) | 0.0 | $215k | 178.00 | 1207.87 | |
| Regulus Therapeutics | 0.0 | $99k | 493k | 0.20 |
